You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HDLS, Leukoencephalopathy

Showing 1 - 25 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mucopolysaccharidosis Disorders, Hurler Syndrome, Hunter Syndrome Trial in Minneapolis (Stem Cell Transplantation, IMD

Recruiting
  • Mucopolysaccharidosis Disorders
  • +28 more
  • Stem Cell Transplantation
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 1, 2022

Assess CSF1R-related Leukoencephalopathy After Stem Cell

Enrolling by invitation
  • CSF1R-related Leukoencephalopathy
  • +3 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Dec 7, 2021

    ALSP Trial in Englewood, Jacksonville (VGL101)

    Recruiting
    • ALSP
    • Englewood, Colorado
    • +1 more
    Dec 22, 2022

    Adult-Onset Leukoencephalopathy With Axonal Spheroids and

    Recruiting
    • ALSP
    • No intervention
    • San Francisco, California
    • +7 more
    May 13, 2022

    AusCADASIL: An Australian Cohort of CADASIL

    Recruiting
    • Cadasil
      • Newcastle, New South Wales, Australia
      • +4 more
      Nov 18, 2023

      Progressive Multifocal Leukoencephalopathy (PML)

      Recruiting
      • Progressive Multifocal Leukoencephalopathy
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 24, 2023

        Cadasil Trial in Suita (Adrenomedullin)

        Completed
        • Cadasil
        • Suita, Osaka, Japan
          National Cerebral and Cardiovascular Center
        Oct 2, 2023

        Cadasil, Migraine Trial (Fremanezumab, Placebo)

        Withdrawn
        • Cadasil
        • Migraine
        • (no location specified)
        Feb 14, 2022

        Cerebral Autosomal Dominant Arteriopathy With Subcortical

        Recruiting
        • CADASIL
        • Study Procedures
        • Los Angeles, California
        • +11 more
        Jan 24, 2023

        Cerebral Small Vessel Diseases Trial in Germany, Netherlands, United Kingdom (Amlodipine, Losartan, Atenolol)

        Recruiting
        • Cerebral Small Vessel Diseases
        • Munich, Germany
        • +4 more
        Mar 1, 2022

        Multiple Sclerosis Trial in Clermont-Ferrand (Methylprednisolone, Placebo, natalizumab (NTZ))

        Recruiting
        • Multiple Sclerosis
        • Clermont-Ferrand, France
          CHU Clermont-Ferrand
        Jan 5, 2023

        Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy Trial in Madison (Registry)

        Recruiting
        • Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy
        • Registry
        • Madison, Wisconsin
          University of Wisconsin
        Dec 6, 2022

        Crohn Disease Trial in Worldwide (Etrolizumab)

        Active, not recruiting
        • Crohn Disease
        • Arcadia, California
        • +291 more
        Nov 11, 2022

        Macrophages Activation Pattern in X-linked Adrenoleukodystrophy,

        Recruiting
        • Adrenoleukodystrophy
        • +3 more
        • Blood sample collection
        • Le Kremlin-Bicêtre, France
        • +1 more
        Oct 10, 2022

        RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy Trial in Saint Louis, Philadelphia (Crizanlizumab)

        Active, not recruiting
        • RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy
        • Saint Louis, Missouri
        • +1 more
        Jan 27, 2022

        Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and Stroke (NINDS)

        Completed
        • Progressive Multifocal Leukoencephalopathy
        • PyVST
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 24, 2023

        Multiple Sclerosis, Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and

        Not yet recruiting
        • Multiple Sclerosis
        • Progressive Multifocal Leukoencephalopathy
        • 89 Zr-Df-crefmirlimab
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        May 13, 2023

        Multiple Sclerosis (MS) Registries

        Active, not recruiting
        • Progressive Multifocal Leukoencephalopathy
        • Tysabri
        • Cambridge, Massachusetts
          Research Site
        Mar 21, 2022

        Quantifying Disease Progression in LBSL

        Recruiting
        • LBSL
        • Leukoencephalopathies
          • Amsterdam-Zuidoost, Noord-Holland, Netherlands
            Amsterdam UMC
          Feb 28, 2023

          Progressive Multifocal Leukoencephalopathy Trial in France (Collection of blood and urine, Spinal tap, Brain MRI)

          Recruiting
          • Progressive Multifocal Leukoencephalopathy
          • Collection of blood and urine
          • +3 more
          • Bordeaux, France
          • +3 more
          Mar 15, 2022

          Natalizumab Extended Interval Dosing in a French Cohort

          Completed
          • Multiple Sclerosis, Relapsing-Remitting
          • Natalizumab Injection [Tysabri]
          • Bobigny, France
          • +4 more
          Mar 8, 2022

          Multiple Sclerosis Trial in Czechia (Natalizumab)

          Recruiting
          • Multiple Sclerosis
          • Brno, Czechia
          • +14 more
          Feb 2, 2022

          Hypercholesterolemia, Insulin Resistance, Insulin Secretion Trial in Tuebingen (Lowering cholesterol concentrations by PCSK-9

          Recruiting
          • Hypercholesterolemia
          • +2 more
          • Lowering cholesterol concentrations by PCSK-9 inhibitor
          • Tuebingen, Germany
            University of Tuebingen, Department of Internal Medicine IV
          Aug 24, 2022

          Progressive Multifocal Leukoencephalopathy Trial run by the NINDS (NT-I7)

          Recruiting
          • Progressive Multifocal Leukoencephalopathy
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Aug 2, 2022

          HIV, Leukoencephalopathy, Progressive Multifocal Trial in United States (Filgrastim, Cytarabine, Zidovudine)

          Completed
          • HIV Infections
          • Leukoencephalopathy, Progressive Multifocal
          • Aurora, Colorado
          • +8 more
          Oct 28, 2021